Innate Pharma (IPHA)
$3.02 $0.76 (49.03%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$119.00M -
Day's Range
$1.47 - $2.47 -
Volume
2,002,090 -
52 Week Low / High
$1.29 - $3.15 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
IPHA's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 3
- Strong Buy
- 1
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $7.55
- Target Price
Company News
-
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript — Mar 22nd, 2024
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript March 21, 2024 Innate Pharma S.A. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: At this time, I would like to welcome everyone to the Innate Pha...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$